Cargando...
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder
BACKGROUND: Extended-release (XR) naltrexone can prevent relapse to opioid use disorder following detoxification. However, one of the barriers to initiating XR-naltrexone is the recommendation for a 7–10-day period of abstinence from opioids prior to the first dose. OBJECTIVES: The current study eva...
Gardado en:
| Publicado en: | Am J Drug Alcohol Abuse |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7260104/ https://ncbi.nlm.nih.gov/pubmed/31860366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2019.1700265 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|